CCI approves the proposal of Tau Investment to acquire shares in J B Chemicals
August 26, 2020
New Delhi: The Competition Commission of India (CCI) has approved the proposal of Tau Investment to acquire shares in J B Chemicals. The proposed combination envisages acquisition of acquisition of up to 64.90% of share capital of J B Chemicals & Pharmaceuticals Limited by Tau Investment Holdings Pte. Ltd. (Tau Investment).
Tau Investment is a company incorporated in Singapore. It is an indirect wholly owned subsidiary of KKR Asian Fund III L.P. It is an affiliate of funds, vehicles and/or entities managed and/or advised by Kohlberg Kravis Roberts & Co. L.P., which is an indirect subsidiary of KKR & Co. Inc.
J B Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company, headquartered in Mumbai, Maharashtra. Majority of its chemical business and CSR activities are located in Gujarat area, especially in Bharuch. It is listed on BSE Limited and the National Stock Exchange of India Limited.
Recent Stories
- Attempts to divide Kadva - Leuvas; Congress candidate's brother behind anonymous flyers
- Ahmedabad woman orders veg sandwich, gets non-veg instead; complaint filed
- ACB Gujarat nabs class-1 officer, his middleman in bribe case
- Rahul Yaan launched for the 21st time, will fail again: Shah in Gujarat
- Priyanka Gandhi campaigns for Congress in Gujarat
- Western Railways to run 3 pairs of special trains from Udhna and Surat
- IN-SPACe releases guidelines to implement space policy